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OBJECTIVES: Compliance with heart failure treatment
guidelines may improve quality of care and reduce health-
care utilization and costs. For accreditation purposes,
hospitals are required by the Joint Commission on the
Accreditation of Healthcare Organizations (JCAHO) to
measure performance for treatment of patients with heart
failure. The purpose of this study is to determine the effect
of hospital compliance with JCAHO performance 
measures and published guidelines on outcomes of
patients with heart failure (HF). METHODS: Thirty hos-
pitals submitted data on 1340 patients admitted with HF
between January 2, 2002 and March 30, 2002. The data
included patient demographics, HF severity, co-existing
illnesses, and type of medication therapy during hospi-
talization and at discharge. Univariate and multivariate
analyses such as ordinary least square (OLS) regression,
logistic regression, and Cox regression analyses were
applied. RESULTS: Current tobacco use and co-existing
illnesses such as cardiomyopathy and chronic renal
disease were signiﬁcantly associated with longer hospital
length of stay (LOS). Moreover, patients admitted to com-
munity hospitals had a lower inpatient mortality rate.
Patients receiving discharge instructions regarding follow-
up appointment and weight monitoring had signiﬁcantly
lower hospital LOS and mortality. Overall, patients
receiving treatment according to published guidelines 
had lower hospital LOS and inpatient mortality rate.
However, receiving treatment in hospitals with a care plan
for HF had no signiﬁcant impact on LOS or mortality.
CONCLUSIONS: Hospital compliance with JCAHO per-
formance measures and published guidelines is associated
with a signiﬁcant reduction in patient LOS or inpatient
mortality. However, patients treated in hospitals with a
care plan for heart failure had no signiﬁcant change in
LOS or mortality.
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BIAS IN CATEGORICAL MEDICATION
COMPLIANCE ASSESSMENT
Cramer JA
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OBJECTIVE: To demonstrate the bias inherent in using
categorical data for medication compliance assessments.
METHODS: Two datasets from studies in which patients
used electronic monitors (MEMS, AARDEX, Union City,
CA) to record long-term daily dosing were used for analy-
ses comparing categorical compliance (>50%, >60%,
>70%, >80%, >90%). Study A compared an intervention
to improve medication compliance with a usual care
control group in a study of Medication Usage Skills for
Effectiveness Program (MUSE-P) (Cramer, J Nerv Ment
Dis, 1999). Study B assessed compliance as a covariate 
to medication efﬁcacy (Krystal, Cramer, NEJM, 2001).
RESULTS: In Study A, analysis by categories of >50%,
>60%, >70%, >80%, and >90% compliance rates 
provided different results for the comparisons between
the intervention and control groups. The proportions of
Intervention and Control group patients who would have
been considered compliant were 90–87%, 85–71%,
77–61%, 64–34%, 54–24%, respectively by category.
Differences between the intervention and control groups
increased with higher standards of compliance (ratios
1.06, 1.22, 1.30, 1.92, 2.33). In Study B, decreasing pro-
portions of patients met criteria for compliance categories
(56%, 50%, 44%, 35%, 26%, respectively). Changing
categories affected regression models with the primary
outcome. CONCLUSIONS: This exercise demonstrated
the biases that occur when compliance is calculated by
category because of lack of information to support selec-
tion of a category designating appropriate compliance.
Information that would deﬁne a category below which 
a medication is ineffective is available for very few 
medications. Without such information, selection of a
category as a determinant of medication compliance is
inappropriate. This problem was removed by using 
continuous compliance data.
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OBJECTIVES: The literature contains a plethora of 
articles on medication compliance research, however, no
“gold standard” in the measurement of compliance has
been established. The Stage of Change (SOC) construct
measure from the Transtheoretical Model of behavioral
change has recently been validated in medication compli-
ance. The objective of this study is to compare the SOC
measure against Four other validated compliance mea-
sures in patients being treated for diabetes, hypertension,
hypercholesterolemia, hypothyroidism, and hormone
replace therapy. METHODS: A total of 171 male and
female patients in ﬁve primary care physician ofﬁces in
the state of Georgia, USA, completed a face-to-face ques-
tionnaire consisting of the SOC measure, the Medication
Adherence Scale, the Medication Outcomes Survey
(MOS) compliance question, the Brief Medication 
Compliance Questionnaire (BMQ) and sociodemo-
graphic information. Pharmacy reﬁll records (RR) were
collected as the ﬁfth compliance measure. RESULTS:
Pearson correlations ranged from a low of 0.09 between
RR and BMQ to a high of 0.79 between SOC and MOS.
All other correlations ranged between 0.20 and 0.49. All
correlations proved signiﬁcantly different than zero (p <
0.05) with the exception of the RR and BMQ correlation.
CONCLUSIONS: The majority of correlations between
validated measures of compliance ranged from weak to
moderate in strength. Therefore the results of this study
show selection of a useful compliance measure is difﬁcult.
The study ﬁndings emphasize that assessing medication-
taking behavior of patients and comparing the results of
different compliance studies is problematic. The develop-
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ment of valid and reliable measures for compliance
behavior is still needed.
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THE INFLUENCE OF SELF-EFFICACY AND
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TRACT INFECTIOUS PATIENTS WHO NEED
SHORT COURSE ANTIBIOTICS AT FORT
ADISORN HOSPITAL,THAIALND 2000
Auamnoy Ti,Auamnoy Th
Chulalongkorn University, Bangkok,Thailand
OBJECTIVE: This study: 1) investigates the relationship
between Self-efﬁcacy (SE) (conﬁdence in competent in a
speciﬁc situation) and compliance with medical regimens
in three groups of patients namely: Chronic maintenance
care for diabetes—a life-threatening illness; Similar 
care for hypertension—a non-life threatening disease, and
Acute care with antibiotics for infection—an episodic 
disorder with or without life-threatening potential; 2)
explores SE for different levels of compliance (with 3 
diseases) in self-administration of prescribed drugs; 3)
identiﬁes other variables relating to compliance in the
respondents at Adisorn Fort, Saraburi Province, Thailand
2001. METHOD: A descriptive cross-sectional survey
was employed to study relationships between SE and
compliance. The response rate was 100% (n = 180). De
Geese’s SE Scale had alpha .8680 and Sorofman’s 
Compliance scale with 2 constructs (correct amount and
correct time) had alpha .8280 and .9459. RESULTS:
Research conﬁrmed that the stronger a patient’s Self-
efﬁcacy, the more reliably he/she complied to regimens 
for self-administration of maintenance and acute-care
medication. SE selectively predicted adherence in 3 dis-
tinct categories of drug therapy: Diabetes > Hypertension
> Antibiotics and compliance in Diabetes > Hypertension
> Antibiotics as well (p < .05). Statistical signiﬁcance for
predicting compliance was found in SE model (R2.695).
Male had more SE and comply than female (p < .05).
There were inverse correlation between education and SE
and negatively correlation between SE and compliance as
well (R-.199,-.189). The length of time for patients got
disease correlated to SE and compliance (R.475, .508) (p
< .05). The elderly had the more SE and more compliance
to medical regimens than the younger (R .415, .404).
Social support inﬂuenced SE and compliance. Patients
with spouses had more SE and more comply with medical
regimens than patients who lived alone (p < .05). CON-
CLUSION: SE played an important role in predicting
compliance. SE was selective among diseases.
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OBJECTIVE: Compliance with chronic medications 
is poor, resulting in lost clinical beneﬁts and wasted
resources. Developing evidence-based compliance pro-
grams is difﬁcult because the literature is often equivocal,
contradictory, or of poor methodological quality. The
objectives of this study were: 1) to assess the relationship
between methodological rigor in program evaluation and
probability of intervention success; and 2) to identify 
the characteristics of compliance interventions that most
strongly predict positive outcomes. METHODS: We
searched the MEDLINE database for controlled studies
of interventions designed to improve patient compliance
with prescription medications for asthma, dyslipidemia,
hypertension, depression, and diabetes (English-only,
published between 1982 and 2002). Each study was
abstracted for methodological rigor and intervention
design. Compliance programs were considered “success-
ful” if the authors demonstrated a statistically signiﬁcant
improvement in compliance compared to a control group.
RESULTS: Sixty-four controlled studies were identiﬁed,
in which 76 compliance interventions were evaluated.
Overall, 68% of the interventions improved compliance.
Of 20 interventions evaluated based on self-reported
compliance, 9 (45%) were successful; 41 of 54 interven-
tions (76%) that measured compliance via pill count,
electronic monitoring, or pharmacy records were suc-
cessful (p = 0.02). There were nine broad categories 
of intervention types, the most frequent of which were
improved dosing convenience (n = 20 interventions, 
70% successful), intensive clinician management (n = 7,
57% successful), counseling (n = 7, 57% successful), and
reminders (n = 6, 66% successful). In addition, 20 of 
25 programs (80%) consisting of multiple interventions
were successful. CONCLUSION: Reliance on self-
reported medication use appears to bias results against
the intervention. This may be because patients report
exaggerated levels of compliance in both intervention 
and control groups, creating a “ceiling effect” that
reduces the observable difference. Common attributes of
successful programs included simpliﬁed treatment 
regimens, facilitation of provider-patient relationships,
and multi-faceted patient education methods. Combina-
tion interventions had higher rates of success than indi-
vidual tactics.
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OBJECTIVES: We deﬁne “compliance” as the “the extent
of correspondence between the patient’s dosing history
and the prescribed dosing regimen”, and “persistence” as
the time between the ﬁrst- and last-taken doses. They are
related in that persistence increases one dose at a time.
